๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

163. Remission induction therapy of refractory acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA)

โœ Scribed by Ohno, R; Yoshida, H; Naoe, T; Ohshima, T; Dohi, H; Endo, N; Fujimoto, T; Kobayashi, T; Hiraoka, A; Kodera, Y

Book ID
123068193
Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
131 KB
Volume
46
Category
Article
ISSN
0753-3322

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

ALL-TRANS RETINOIC ACID (ATRA) IN THE TR
ALL-TRANS RETINOIC ACID (ATRA) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL)
โœ C. S. CHIM; Y. L. KWONG; R. LIANG; Y. C. CHU; C. H. CHAN; L. C. CHAN; K. F. WONG ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 498 KB ๐Ÿ‘ 2 views

Acute promyelocytic leukemia is characterized by the reciprocal translocation of chromosomes 15 and 17. All-trans retinoic acid (ATRA) efficiently induces differentiation of the abnormal promyelocytes. In this study, we had used ATRA as the primary induction therapy for 17 newly diagnosed patients,

Acute promyelocytic leukemia: All-trans
Acute promyelocytic leukemia: All-trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA alone
โœ Advani, Suresh H.; Nair, Reena; Bapna, Ajay; Gladstone, Betty; Kadam, Pratibha; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 61 KB ๐Ÿ‘ 2 views

This study was conducted to compare the results of treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid alone (ATRA) or a combination therapy of ATRA followed by chemotherapy. Forty-three patients treated between February 1992 and February 1996 were included in this study. Ei